These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
423 related articles for article (PubMed ID: 31362244)
1. Curcumin attenuates potassium oxonate-induced hyperuricemia and kidney inflammation in mice. Chen Y; Li C; Duan S; Yuan X; Liang J; Hou S Biomed Pharmacother; 2019 Oct; 118():109195. PubMed ID: 31362244 [TBL] [Abstract][Full Text] [Related]
2. Astaxanthin attenuated hyperuricemia and kidney inflammation by inhibiting uric acid synthesis and the NF-κ B/NLRP3 signaling pathways in potassium oxonate and hypoxanthine-induced hyperuricemia mice. Zhuang J; Zhou X; Liu T; Zhang S; Yuan F; Zhang L; Yang Z; Chen Y Pharmazie; 2021 Nov; 76(11):551-558. PubMed ID: 34782040 [TBL] [Abstract][Full Text] [Related]
3. 9-Hydroxy-8-oxypalmatine, a novel liver-mediated oxymetabolite of palmatine, alleviates hyperuricemia and kidney inflammation in hyperuricemic mice. Wu X; Huang R; Ai G; Chen H; Ma X; Zhang J; Huang Q; Lao J; Zeng H; Li C; Xie J; Li Y; Su Z; Chen J; Huang X J Ethnopharmacol; 2024 Dec; 335():118606. PubMed ID: 39038504 [TBL] [Abstract][Full Text] [Related]
4. Siwu decoction attenuates oxonate-induced hyperuricemia and kidney inflammation in mice. Wang R; Ma CH; Zhou F; Kong LD Chin J Nat Med; 2016 Jul; 14(7):499-507. PubMed ID: 27507200 [TBL] [Abstract][Full Text] [Related]
5. Astilbin improves potassium oxonate-induced hyperuricemia and kidney injury through regulating oxidative stress and inflammation response in mice. Wang M; Zhao J; Zhang N; Chen J Biomed Pharmacother; 2016 Oct; 83():975-988. PubMed ID: 27522260 [TBL] [Abstract][Full Text] [Related]
6. Chen J; Xu L; Jiang L; Wu Y; Wei L; Wu X; Xiao S; Liu Y; Gao C; Cai J; Su Z Food Funct; 2021 Oct; 12(19):9416-9431. PubMed ID: 34606558 [No Abstract] [Full Text] [Related]
7. Fuling-Zexie formula attenuates hyperuricemia-induced nephropathy and inhibits JAK2/STAT3 signaling and NLRP3 inflammasome activation in mice. Lu M; Yin J; Xu T; Dai X; Liu T; Zhang Y; Wang S; Liu Y; Shi H; Zhang Y; Mo F; Sukhorukov V; Orekhov AN; Gao S; Wang L; Zhang D J Ethnopharmacol; 2024 Jan; 319(Pt 2):117262. PubMed ID: 37788785 [TBL] [Abstract][Full Text] [Related]
8. Nuciferine restores potassium oxonate-induced hyperuricemia and kidney inflammation in mice. Wang MX; Liu YL; Yang Y; Zhang DM; Kong LD Eur J Pharmacol; 2015 Jan; 747():59-70. PubMed ID: 25499818 [TBL] [Abstract][Full Text] [Related]
9. Hypouricemic and nephroprotective effects of palmatine from Cortex Phellodendri Amurensis: A uric acid modulator targeting Keap1-Nrf2/NLRP3 axis. Ai G; Huang R; Xie J; Zhong L; Wu X; Qin Z; Su Z; Chen J; Yang X; Dou Y J Ethnopharmacol; 2023 Jan; 301():115775. PubMed ID: 36198377 [TBL] [Abstract][Full Text] [Related]
10. 4-(2-(4-chlorophenyl)-1-((4-chlorophenyl)amino)ethyl)benzene-1, 3-diol is a potential agent for gout therapy as a dual inhibitor of XOD and NLRP3. Zhou M; Li S; Song L; Hu Q; Liu W Phytomedicine; 2018 Mar; 42():9-17. PubMed ID: 29655702 [TBL] [Abstract][Full Text] [Related]
11. Simiao San alleviates hyperuricemia and kidney inflammation by inhibiting NLRP3 inflammasome and JAK2/STAT3 signaling in hyperuricemia mice. Zhang Y; Wang S; Dai X; Liu T; Liu Y; Shi H; Yin J; Xu T; Zhang Y; Zhao D; Sukhorukov V; Orekhov AN; Gao S; Wang L; Zhang D J Ethnopharmacol; 2023 Aug; 312():116530. PubMed ID: 37098372 [TBL] [Abstract][Full Text] [Related]
12. Phloretin ameliorates hyperuricemia-induced chronic renal dysfunction through inhibiting NLRP3 inflammasome and uric acid reabsorption. Cui D; Liu S; Tang M; Lu Y; Zhao M; Mao R; Wang C; Yuan Y; Li L; Chen Y; Cheng J; Lu Y; Liu J Phytomedicine; 2020 Jan; 66():153111. PubMed ID: 31790902 [TBL] [Abstract][Full Text] [Related]
13. Protective effects of Rhizoma smilacis glabrae extracts on potassium oxonate- and monosodium urate-induced hyperuricemia and gout in mice. Liang G; Nie Y; Chang Y; Zeng S; Liang C; Zheng X; Xiao D; Zhan S; Zheng Q Phytomedicine; 2019 Jun; 59():152772. PubMed ID: 31005813 [TBL] [Abstract][Full Text] [Related]
14. Polydatin attenuates potassium oxonate-induced hyperuricemia and kidney inflammation by inhibiting NF-κB/NLRP3 inflammasome activation via the AMPK/SIRT1 pathway. Chen L; Lan Z Food Funct; 2017 May; 8(5):1785-1792. PubMed ID: 28428988 [TBL] [Abstract][Full Text] [Related]
15. Hypouricemic and Nephroprotective Effects of an Active Fraction from Polyrhachis Vicina Roger On Potassium Oxonate-Induced Hyperuricemia in Rats. Su Q; Su H; Nong Z; Li D; Wang L; Chu S; Liao L; Zhao J; Zeng X; Ya Q; He F; Lu W; Wei B; Wei G; Chen N Kidney Blood Press Res; 2018; 43(1):220-233. PubMed ID: 29490297 [TBL] [Abstract][Full Text] [Related]
16. RIP3-deficience attenuates potassium oxonate-induced hyperuricemia and kidney injury. Wang K; Hu L; Chen JK Biomed Pharmacother; 2018 May; 101():617-626. PubMed ID: 29518608 [TBL] [Abstract][Full Text] [Related]
17. Effects of ChondroT on potassium Oxonate-induced Hyperuricemic mice: downregulation of xanthine oxidase and urate transporter 1. Oh DR; Kim JR; Choi CY; Choi CH; Na CS; Kang BY; Kim SJ; Kim YR BMC Complement Altern Med; 2019 Jan; 19(1):10. PubMed ID: 30621705 [TBL] [Abstract][Full Text] [Related]
18. Berberrubine attenuates potassium oxonate- and hypoxanthine-induced hyperuricemia by regulating urate transporters and JAK2/STAT3 signaling pathway. Lin G; Yu Q; Xu L; Huang Z; Mai L; Jiang L; Su Z; Xie J; Li Y; Liu Y; Lin Z; Chen J Eur J Pharmacol; 2021 Dec; 912():174592. PubMed ID: 34699754 [TBL] [Abstract][Full Text] [Related]
19. Impact of Xu Y; Cao X; Zhao H; Yang E; Wang Y; Cheng N; Cao W Nutrients; 2021 Jul; 13(8):. PubMed ID: 34444825 [No Abstract] [Full Text] [Related]
20. Oxyberberrubine, a novel liver microsomes-mediated secondary metabolite of berberine, alleviates hyperuricemic nephropathy in mice. Zhong L; Lin Y; Gong S; Wu X; Liu Y; Chen J; Li Y; Yan F; Su Z; Xie Q Phytomedicine; 2023 Jan; 108():154521. PubMed ID: 36334387 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]